InsiderPulse| Trade Date | Filed | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | 2026-05-13 | Fairmount Funds Management LLC | Director | Purchase | 1.18M | $17.00 | $20.00M | 5.09M | View ↗ | |
| 2025-10-23 | 2025-10-27 | Fairmount Funds Management LLC | Director | Purchase | 454.5K | $22.00 | $10.00M | 3.91M | View ↗ |
No annual data found.
Viridian Therapeutics to Participate in Upcoming June Investor Conferences
Viridian Therapeutics (VRDN) Prices Upsized Concurrent Public Offerings Totaling $350M
This Biotech Has a June 30 FDA Catalyst. A Fund Just Cut Its Stake by $7 Million
Earnings High Fliers And Busts